T Staging of Oral Pharyngeal Squamous Cell Carcinoma (OPSCC) Human Papilloma Virus (HPV) Negative

  • NCCN Guidelines, Head and Neck Cancers (v2.2026) still base clinical staging definitions on AJCC 8th edition (ST-4 for p16-negative, ST-7 for p16-positive):
    • Version 9 is not yet incorporated
  • Version 9 changes apply only to:
    • HPV-positive (p16+) oropharyngeal carcinoma
  • The p16-negative oropharynx / hypopharynx system:
    • Is unchanged in the current NCCN tables
  • T – Tumor:
    • TX – Primary tumor cannot be assessed
    • Tis – Carcinoma in situ
    • T1 – Tumor 2 cm or smaller in greatest dimension
    • T2 – Tumor larger than 2 cm but not larger than 4 cm in greatest dimension
    • T3 – Tumor larger than 4 cm in greatest dimensión or extensión to lingual surface of epiglottis
    • T4 – Moderately advanced or very advanced local disease
      • T4a – Moderately advanced local disease
        • Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid muscle, hard palate, or mandible
      • T4b – Very advanced local disease
        • Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery
#Arrangoiz #HeadandNeckSurgeon #CancerSurgeon #SurgicalOncology #OropharyngealCancer #Teacher #Surgeon #MountSinaiMedicalCenter #MSMC #BramanComprehensiveCancerCenter #BCCC #Miami #Mexico

Leave a comment